Newborn screen testing

Ended Awarded Last action

Contract number
W9114F20F0037
Awardee
Awarding agency
Obligated
$82,500

Award facts

Opportunity
Contract value 100% obligated
$82,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Germany

Award details come from SAM.gov/FPDS.

About this award

This is a delivery order contract awarded by the Medical Command, a defense agency, to Revvity Omics Inc., doing business as Perkinelmer Genetics, for a total ceiling value of $82,500.00. The contract is for newborn screening testing services to be provided in Germany. The award is not associated with a larger contract vehicle, and there is no set-aside designation indicated. Perkinelmer Genetics is a subsidiary of the parent company Revvity Inc., which specializes in medical imaging and genetic testing services. The contract supports the military healthcare system by providing newborn screening, which allows for early detection and treatment of life-threatening conditions in infants.

Quick answers

Who was awarded contract W9114F20F0037?

W9114F20F0037 was awarded to Revvity Omics Inc. by Medical Command (Department of the Army) on September 1, 2020.

How much is contract W9114F20F0037 worth?

The government has obligated $82,500 on W9114F20F0037.

Is contract W9114F20F0037 an order under another contract?

Yes. W9114F20F0037 is a delivery order under W9114F16D0004, an indefinite delivery contract.

Was contract W9114F20F0037 competed?

The extent of competition for W9114F20F0037 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award